IMAC Holdings, Inc. (BACK)
OTCMKTS · Delayed Price · Currency is USD
0.0710
0.00 (0.00%)
Aug 15, 2025, 2:17 PM EDT
IMAC Holdings Employees
IMAC Holdings had 15 employees as of December 31, 2024. The number of employees increased by 11 or 275.00% compared to the previous year.
Employees
15
Change (1Y)
11
Growth (1Y)
275.00%
Revenue / Employee
$3,853
Profits / Employee
-$887,039
Market Cap
268.73K
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 15 | 11 | 275.00% |
Dec 31, 2023 | 4 | -81 | -95.29% |
Dec 31, 2022 | 85 | -92 | -51.98% |
Dec 31, 2021 | 177 | 38 | 27.34% |
Dec 31, 2020 | 139 | 7 | 5.30% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Tian'an Technology Group | 8 |
Glass House Brands | 374 |
Elite Pharmaceuticals | 68 |
American Oncology Network | 1,914 |
Northwest Biotherapeutics | 25 |
CytoDyn | 13 |
Silence Therapeutics | 116 |
IMAC Holdings News
- 9 days ago - IMAC Holdings Announces Research Collaboration with Vanderbilt University Medical Center to Advance Immuno-Oncology Biomarker Discovery - GlobeNewsWire
- 6 months ago - Ignite Proteomics to Present Data on MHC-II as a Predictor of Pembrolizumab Response at NCCN Annual Conference - GlobeNewsWire
- 6 months ago - Ignite Proteomics Completes Acquisition of PLA Code 0249U for Its Advanced Proteomic Breast Cancer Assay - GlobeNewsWire
- 6 months ago - Ignite Proteomics Announces Publication of Study Demonstrating Superiority of Protein Activation Analysis in Predicting Breast Cancer Therapy Response - GlobeNewsWire
- 7 months ago - IMAC Holdings Introduces Ignite Proteomics: A New Standard for Matching Patients with the Right Cancer Therapies - GlobeNewsWire
- 9 months ago - IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q - GlobeNewsWire
- 9 months ago - IMAC Holdings Granted Extension by Nasdaq to Regain Compliance with Listing Rule 5250(c)(1) - GlobeNewsWire
- 11 months ago - IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology - GlobeNewsWire